Boston Research & Management’s Mandiant, Inc. Common Stock MNDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MNDT
SCM
Boston Research & Management's MNDT Position: Q1 2021 in Review
Boston Research & Management sold out of Mandiant, Inc. Common Stock (MNDT) in Q1 2021, closing a stake of 18,900 shares — an estimated $435K sold.
Boston Research & Management first reported a position in MNDT in Q1 2017 and held it in 16 quarters. The position peaked at $435K in Q4 2020. 334 funds tracked by Wall St. Rank hold MNDT as of Q1 2021.
- Boston Research & Management reported no remaining Mandiant, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
- Boston Research & Management sold 18,900 Mandiant, Inc. Common Stock shares in Q1 2021, an estimated $435K.
- Boston Research & Management first reported a position in Mandiant, Inc. Common Stock in Q1 2017 and held it in 16 quarters.
- Boston Research & Management's Mandiant, Inc. Common Stock position peaked at $435K in Q4 2020.
- 334 funds tracked by Wall St. Rank held Mandiant, Inc. Common Stock as of Q1 2021.
Based on Boston Research & Management's 13F filing for Q1 2021, filed 11 May 2021.